<p>Median (range) of lapatinib concentrations in tumor, plasma, and their ratios.</p
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampli...
<p>Median Plasma concentrations (range) of silibinin, dihydrogen succinate silibinin and their respe...
<p>Average GI<sub>50</sub> and TGI values for lapatinib in 22 HER2 positive breast cancer cell lines...
<p>Median (range) lapatinib exposure in mouse (n = 3) tumor, blood, and plasma after the fifth dose ...
<p>Concentration (median and range) for individual protein biomarkers measured in the serum of cance...
<p>Women with early stage HER2+ breast cancer were randomized to oral lapatinib monotherapy at 500 m...
The paradigm shift in cancer treatment from cytotoxic drugs to tumor targeted therapies poses new ch...
<p>The values are represented as the medians with interquartile ranges.</p><p>Plasma concentrations ...
<p>Concentrations (medians and interquartile ranges) of NT-proBNP (A) and cTnI (B) in patients with ...
<p>BLQ; Below the level of quantification</p><p>Pharmacokinetic data are summarized as median (inter...
<p>Medians with interquartile ranges of thrombin generation parameters in plasma.</p
Median (IQR) plasma concentrations in original units according to control or intervention group at e...
<p>Median duration of chemotherapy broken down by clinical and pathological parameters.</p
Median (IQR) plasma concentrations in original units according to control or intervention group at e...
<p>Concentrations (µM) and levels of 11 small molecules used with imatinib in the combinatorial drug...
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampli...
<p>Median Plasma concentrations (range) of silibinin, dihydrogen succinate silibinin and their respe...
<p>Average GI<sub>50</sub> and TGI values for lapatinib in 22 HER2 positive breast cancer cell lines...
<p>Median (range) lapatinib exposure in mouse (n = 3) tumor, blood, and plasma after the fifth dose ...
<p>Concentration (median and range) for individual protein biomarkers measured in the serum of cance...
<p>Women with early stage HER2+ breast cancer were randomized to oral lapatinib monotherapy at 500 m...
The paradigm shift in cancer treatment from cytotoxic drugs to tumor targeted therapies poses new ch...
<p>The values are represented as the medians with interquartile ranges.</p><p>Plasma concentrations ...
<p>Concentrations (medians and interquartile ranges) of NT-proBNP (A) and cTnI (B) in patients with ...
<p>BLQ; Below the level of quantification</p><p>Pharmacokinetic data are summarized as median (inter...
<p>Medians with interquartile ranges of thrombin generation parameters in plasma.</p
Median (IQR) plasma concentrations in original units according to control or intervention group at e...
<p>Median duration of chemotherapy broken down by clinical and pathological parameters.</p
Median (IQR) plasma concentrations in original units according to control or intervention group at e...
<p>Concentrations (µM) and levels of 11 small molecules used with imatinib in the combinatorial drug...
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampli...
<p>Median Plasma concentrations (range) of silibinin, dihydrogen succinate silibinin and their respe...
<p>Average GI<sub>50</sub> and TGI values for lapatinib in 22 HER2 positive breast cancer cell lines...